Pancreatic islet transplantation after upper abdominal exenteration and liver replacement.

PubWeight™: 4.18‹?› | Rank: Top 1%

🔗 View Article (PMC 2972674)

Published in Lancet on August 18, 1990

Authors

A G Tzakis1, C Ricordi, R Alejandro, Y Zeng, J J Fung, S Todo, A J Demetris, D H Mintz, T E Starzl

Author Affiliations

1: Department of Surgery, Medicine, University of Pittsburgh, Pennsylvania 15213.

Articles citing this

Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg (1995) 2.25

Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation (1992) 2.20

Use of FK 506 in pediatric patients. Transplant Proc (1991) 1.77

Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice. J Clin Invest (1993) 1.75

Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest (1996) 1.50

Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients. Transplant Proc (1991) 1.41

Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg (1995) 1.37

Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg (1997) 1.36

Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg (1997) 1.29

Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (WF rat----B10 mouse). Transplantation (1992) 1.23

Tacrolimus in pediatric renal transplantation. Transplantation (1996) 1.18

Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg (2004) 1.15

A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc (1995) 1.13

Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century. Stem Cells Int (2015) 1.12

Human islet isolation and purification from pediatric-age donors. Transplant Proc (1991) 1.09

Current status of islet cell transplantation. J Hepatobiliary Pancreat Surg (2008) 1.07

Ultrastructural evidence for blood microvessels devoid of an endothelial cell lining in transplanted pancreatic islets. Am J Pathol (1995) 1.01

Microbiologic surveillance as part of human islet transplantation: results of the first 26 patients. Transplant Proc (1992) 1.01

Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome. Rev Diabet Stud (2012) 0.99

Composition of human islet cell preparations for transplantation. Acta Diabetol (1992) 0.97

Animal models of diabetes mellitus for islet transplantation. Exp Diabetes Res (2012) 0.96

The effect of prednisone on pancreatic islet autografts in dogs. Surgery (1993) 0.92

Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles. World J Surg (2000) 0.90

Revascularization and remodelling of pancreatic islets grafted under the kidney capsule. J Anat (2007) 0.89

In vivo effect of FK506 on human pancreatic islets. Transplantation (1991) 0.89

Human islet allotransplantation under FK 506. Transplant Proc (1991) 0.89

Islet transplantation for type 1 diabetes, 2015: what have we learned from alloislet and autoislet successes? Diabetes Care (2015) 0.88

Insulin independence for 58 months following pancreatic islet cell transplantation in a patient undergoing upper abdominal exenteration. Transplant Proc (1995) 0.88

Encapsulated cell grafts to treat cellular deficiencies and dysfunction. Crit Rev Biomed Eng (2011) 0.88

Pancreatic islet transplantation. World J Gastrointest Surg (2009) 0.86

Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation. J Transplant (2011) 0.85

Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival. J Pediatr Surg (1992) 0.85

The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience. Clin Transpl (1995) 0.85

Thrombosis and inflammation in intraportal islet transplantation: a review of pathophysiology and emerging therapeutics. J Diabetes Sci Technol (2008) 0.82

Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants. Am J Pathol (1992) 0.81

Transplantation of islet allografts and xenografts in totally pancreatectomized diabetic dogs using the hybrid artificial pancreas. Ann Surg (1991) 0.80

Update on islet cell transplantation for type 1 diabetes. Semin Intervent Radiol (2012) 0.80

Detection of pancreatic islet tissue following islet allotransplantation in man. Transplantation (1991) 0.79

Two-year experience with FK 506 in pediatric patients. Transplant Proc (1993) 0.78

Induction of Pancreatic Islet Graft Acceptance: The Role of Antigen Presenting Cells. Transplant Sci (1992) 0.78

Pancreas and islet cell transplantation. Best Pract Res Clin Gastroenterol (2002) 0.78

Renal transplantation at the University of Pittsburgh: the impact of FK506. Clin Transpl (1994) 0.78

Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras. Transplant Proc (1992) 0.77

Management of insulin-dependent diabetes mellitus. Drugs (1992) 0.77

Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (F344 rat to B10 mouse). Transplant Proc (1992) 0.77

Pathophysiology of diabetes. A review of selected recent developments and their impact on treatment. Drugs (1992) 0.76

Glucose homeostasis is regulated by donor islets in xenografts. Transplant Proc (1992) 0.76

From Beta cell replacement to beta cell regeneration: implications for antidiabetic therapy. J Diabetes Sci Technol (2014) 0.76

Evidence that canine pancreatic islets promote the survival of human hepatocytes in nude mice. Transplantation (1991) 0.76

Human islet allotransplantation in 18 diabetic patients. Transplant Proc (1992) 0.76

Brief review: cell replacement therapies to treat type 1 diabetes mellitus. Clin Diabetes Endocrinol (2016) 0.75

Intrahepatic human islet transplantation at the University of Pittsburgh: results in 25 consecutive cases. Transplant Proc (1992) 0.75

Pancreatic islet transplantation. Lancet (1990) 0.75

Histologic finding of pancreatic islet tissue following intraportal human islet allotransplantation. Transplant Proc (1992) 0.75

Detection of intrahepatic human islets following combined liver-islet allotransplantation. Pancreas (1992) 0.75

Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice. Transplant Proc (1992) 0.75

Who Should Be Considered for Islet Transplantation Alone? Curr Diab Rep (2017) 0.75

Outcome of human islet isolation and allotransplantation in 20 consecutive cases. Diabetes Nutr Metab (1992) 0.75

Liver transplantation for malignancy. Br J Cancer (1991) 0.75

Effect of FK 506 on function of human islets of Langerhans. Transplant Proc (1991) 0.75

The use of FK 506 in new-onset type I diabetes in man. Transplant Proc (1991) 0.75

Preventing long term complications. Implications for combination therapy with acarbose. Drugs (1992) 0.75

Articles cited by this

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Automated method for isolation of human pancreatic islets. Diabetes (1988) 8.23

Kidney transplantation under FK 506. JAMA (1990) 7.45

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

An improved technique for multiple organ harvesting. Surg Gynecol Obstet (1987) 4.73

Principles of solid-organ preservation by cold storage. Transplantation (1988) 3.79

Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Invest (1983) 3.21

Islet isolation assessment in man and large animals. Acta Diabetol Lat (1991) 2.89

Insulin independence after islet transplantation into type I diabetic patient. Diabetes (1990) 2.57

Upper abdominal exenteration with liver replacement: a modification of the "cluster" procedure. Transplant Proc (1990) 2.40

A simple method of staining fresh and cultured islets. Transplantation (1988) 2.03

Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus. N Engl J Med (1983) 2.00

Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator. Diabetes (1989) 1.81

A method for isolation of islets of Langerhans from the human pancreas. Diabetes (1984) 1.60

Isolation of the elusive pig islet. Surgery (1990) 1.56

Isolation of pancreatic islets from dogs. Semiautomated purification on albumin gradients. Transplantation (1990) 1.39

Developments in isolated pancreatic islet transplantation. Transplantation (1987) 1.30

Human islet transplantation in patients with type I diabetes. Transplant Proc (1989) 1.22

Defect of the first-phase insulin secretion to glucose stimulation in the perfused pancreas of the nonobese diabetic (NOD) mouse. Diabetes (1986) 1.19

Continued function of pancreatic islets after transplantation in type I diabetes. Lancet (1989) 1.05

Studies of the isolation and viability of human islets of Langerhans. Transplantation (1988) 1.03

Islet cell transplantation in type I diabetes mellitus. Transplant Proc (1987) 1.02

Combined liver and pancreatic islet transplantation in the rat. Transplantation (1983) 1.00

Longitudinal study of first phase insulin release in the BB rat. Diabetologia (1986) 0.94

Natural history of multiple intrahepatic canine islet allografts during and following administration of cyclosporine. Transplantation (1988) 0.93

Isolation and quantification of canine islet tissue for transplantation. Transplantation (1987) 0.91

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

Gene therapy restores vision in a canine model of childhood blindness. Nat Genet (2001) 7.88

Biodemographic trajectories of longevity. Science (1998) 7.78

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39

Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science (1992) 5.36

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Intestinal transplantation in composite visceral grafts or alone. Ann Surg (1992) 4.96

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc Natl Acad Sci U S A (1996) 4.61

Liver transplantation (1). N Engl J Med (1989) 4.53

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc Natl Acad Sci U S A (1994) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses. J Biomech (1994) 3.76

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet (1997) 3.70

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. Surg Res Commun (1987) 3.46